- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Aclarion stock price target cut to $20 at Ascendiant Capital | 2 | Investing.com | ||
| ACLARION Aktie jetzt für 0€ handeln | |||||
| Fr | Kursziel für Aclarion-Aktie von Ascendiant Capital auf 20 US-Dollar gesenkt | 1 | Investing.com Deutsch | ||
| 26.05. | XFRA NEW INSTRUMENTS AVAILABLE ON 26.05.2025 | 285 | Xetra Newsboard | The following instruments on XETRA do have their first trading 26.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.05.2025
Aktien
1 MXCFFM010000 Banco Invex S.A.
2... ► Artikel lesen | |
| 20.05. | Aclarion, Inc.: Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site | 9 | GlobeNewswire (USA) | ||
| 15.05. | Aclarion, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.05. | Aclarion, Inc.: Aclarion Announces Texas Back Institute as New CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 05.05. | Aclarion, Inc.: Aclarion Welcomes Advocate Health as CLARITY Trial Site | 2 | GlobeNewswire (USA) | ||
| 29.04. | Aclarion, Inc.: Aclarion Announces Commercial Agreement with Spine Institute of Louisiana | 4 | GlobeNewswire (USA) | ||
| 23.04. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.04. | Aclarion, Inc.: Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 | 2 | GlobeNewswire (USA) | ||
| 21.04. | Aclarion, Inc.: Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis | 2 | GlobeNewswire (USA) | ||
| 09.04. | Aclarion, Inc.: Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub | 1 | GlobeNewswire (USA) | ||
| 09.04. | Aclarion, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 02.04. | Aclarion, Inc.: Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California | 1 | GlobeNewswire (USA) | ||
| 28.03. | Aclarion, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 26.03. | Aclarion looks to conduct reverse stock split | 6 | Seeking Alpha | ||
| 26.03. | Aclarion, Inc.: Aclarion Announces Reverse Stock Split | 150 | GlobeNewswire (Europe) | BROOMFIELD, Colo., March 26, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary... ► Artikel lesen | |
| 13.03. | Aclarion, Inc. - 8-K, Current Report | 9 | SEC Filings | ||
| 06.03. | Aclarion Stock Plunges 80% Amid Expansion Announcements | 5 | RTTNews | ||
| 06.03. | Aclarion announces expansion plans with RadNet affiliates in NY, NJ | 3 | Seeking Alpha |
Seite:
1 2 3 Weiter >>
51 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 488,45 | -0,06 % | How Is Intuitive Surgical's Stock Performance Compared to Other Healthcare Stocks? | ||
| UNITEDHEALTH | 263,15 | -0,04 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: UnitedHealth, Flatexdegiro und Friedrich Vorwerk! | Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 10:00 Uhr, Deutschland: Friedrich... ► Artikel lesen | |
| ROKU | 64,43 | -0,19 % | Should Investors Buy Roku Stock Instead of Netflix Stock? | ||
| SERNOVA BIOTHERAPEUTICS | 0,108 | -0,92 % | Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy | Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,750 | +0,27 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,779 | -2,19 % | PA GOODDOCTOR (01833): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports First Quarter 2025 Financial Results and Provides Business Update | SAN DIEGO, May 15, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM), today announced financial results for the first quarter... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,019 | +27,40 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,256 | 0,00 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| CENTENE | 48,650 | +1,05 % | Aktie von Centene büßt 4,00 Prozent ein (47,4008 €) | An der US-amerikanischen Börse notiert das Wertpapier von Centene derzeit ein wenig leichter. Der jüngste Kurs betrug 54,18 US-Dollar. Für Inhaber von Centene ist der heutige Handelstag bisher nicht... ► Artikel lesen | |
| VERU | 0,558 | -2,28 % | Tootsie Roll among names set to join Russell 3000 Index, Growgeneration, Veru set to leave | ||
| CYTOSORBENTS | 0,899 | +1,58 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| QUIDELORTHO | 25,400 | -7,30 % | Quidel auf der 45. jährlichen William Blair Growth Stock Konferenz: Strategische Schritte und Finanzziele | ||
| TEMPEST THERAPEUTICS | 5,240 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,570 | 0,00 % | VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, May 16 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., May 15, 2025 /PRNewswire/... ► Artikel lesen |
Das Unternehmen ACLARION INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,49 % bei einem Aktienkurs von 5,480 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.